MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

AETHLON MEDICAL INC (AEMD)

AETHLON MEDICAL INC (AEMD)

|||

Balance Sheets Overview

Current Ratio
541.57%
Quick Ratio
541.57%
Cash Ratio
476.19%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Deferred offering cost
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
4,933,579
5,026,458
6,956,397
5,853,493
Australian research and development tax incentive receivable
-
-
-
218,314
Deferred offering cost
394,192
210,985
-
-
Prepaid expenses and other current assets
283,143
332,094
185,122
182,072
Total current assets
5,610,914
5,569,537
7,141,519
6,253,879
Property and equipment, net
293,112
356,822
434,179
513,992
Operating lease right-of-use asset, net
232,195
307,820
382,583
456,496
Patents, net
-
0
138
275
Restricted cash
99,150
98,928
98,709
98,448
Deposits
-
0
0
0
Total assets
6,235,371
6,333,107
8,057,128
7,323,090
Accounts payable
411,373
384,550
469,452
570,792
Due to related parties
68,250
68,250
237,846
248,454
Operating lease liability, current portion
255,052
336,718
330,628
324,656
Other current liabilities
301,367
657,317
219,211
261,095
Total liabilities, all current
1,036,042
1,446,835
1,257,137
1,404,997
Operating lease liability, less current portion
-
0
86,894
172,116
Total liabilities
-
1,446,835
1,344,031
1,577,113
Common stock, par value 0.001 per share 20,000,000 shares authorized as of june 30, 2026 and march 31, 2026 477,402 shares issued and outstanding as of june 30, 2026 and 314,100 shares issued and outstanding at march 31, 2026
477
1,570
973
761
Additional paid-in capital
181,891,939
180,023,691
179,963,981
176,975,368
Accumulated other comprehensive loss
-38,889
-32,703
-29,837
-26,377
Accumulated deficit
-176,654,198
-175,106,286
-173,222,020
-171,203,775
Total stockholders equity
5,199,329
4,886,272
6,713,097
5,745,977
Total liabilities and stockholders equity
6,235,371
6,333,107
8,057,128
7,323,090
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$4,933,579 (31.03%↑ Y/Y)Deferred offering cost$394,192 (4230.35%↑ Y/Y)Prepaid expenses andother current assets$283,143 (2.37%↑ Y/Y)Total current assets$5,610,914 (38.51%↑ Y/Y)Property and equipment,net$293,112 (-50.63%↓ Y/Y)Operating leaseright-of-use asset, net$232,195 (-56.15%↓ Y/Y)Restricted cash$99,150 (1.04%↑ Y/Y)Total assets$6,235,371 (17.52%↑ Y/Y)Total liabilities andstockholders equity$6,235,371 (17.52%↑ Y/Y)Total stockholdersequity$5,199,329 (51.87%↑ Y/Y)Total liabilities,all current$1,036,042 (-36.34%↓ Y/Y)Accumulated deficit-$176,654,198 (-4.09%↓ Y/Y)Accumulated othercomprehensive loss-$38,889 (-73.79%↓ Y/Y)Additional paid-in capital$181,891,939 (5.04%↑ Y/Y)Accounts payable$411,373 (-28.02%↓ Y/Y)Other currentliabilities$301,367 (-17.33%↓ Y/Y)Operating leaseliability, current portion$255,052 (-20.00%↓ Y/Y)Due to relatedparties$68,250 (-81.68%↓ Y/Y)Common stock, par value0.001 per share...$477 (-81.65%↓ Y/Y)